Aldeyra Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Aldeyra Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$16.1M, a 69% decline year-over-year.
  • Aldeyra Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$49.6M, a 1.5% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$42.8M, a 31.7% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$62.7M, a 11.5% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$56.2M, a 54.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$42.8M +$19.9M +31.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$62.7M -$6.46M -11.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$56.2M -$19.8M -54.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$36.4M +$26.7M +42.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$63.1M -$23.4M -58.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$39.7M -$17.2M -76.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$22.5M -$3.79M -20.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 -$18.7M -$6.71M -55.9% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-30
2015 -$12M -$4.72M -64.9% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$7.27M -$3.59M -97.8% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 -$3.68M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.